Dendritic cell surface and membrane (DC surface)

The dendritic cell (DC) surface and membrane encompass a complex array of proteins essential for the initiation and regulation of adaptive immune responses. As professional antigen-presenting cells, DCs utilize surface-bound Major Histocompatibility Complex (MHC) molecules to present processed antigens to T-cell receptors (Worbs et al., 2017, Nature Reviews Immunology). This interaction is critically regulated by co-stimulatory molecules such as CD80 and CD86, which provide the necessary secondary signals for T-cell proliferation and differentiation (Banchereau & Steinman, 1998, Nature). Additionally, the DC membrane contains various pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and C-type lectin receptors like DC-SIGN, which sense environmental pathogens and trigger DC maturation (Figdor et al., 2002, Nature Reviews Immunology). In clinical oncology and immunology, these surface proteins are targeted to either enhance immune responses against tumors or suppress unwanted immunity in transplantation and autoimmune disorders (Kawai & Akira, 2011, Immunity). Because the term refers to an entire cellular compartment containing hundreds of distinct proteins rather than a single molecular entity, it is classified as a broad category of targets rather than a specific therapeutic target.

Other names

Dendritic cell surface markersDC membrane proteinsDendritic cell immunophenotypeDC plasma membrane

Drugs targeting components of the dendritic cell surface typically act by modulating co-stimulatory signals (e.g., blocking CD80/86 with CTLA-4-Ig), inhibiting checkpoint interactions (e.g., PD-L1/PD-1), or activating pattern recognition receptors (e.g., TLR agonists) to induce maturation and enhance antigen presentation to T-cells.